Lid abscess associated with personal protective eyewear in a COVID-19 medical unit
| Media Type: |
Electronic Article |
|---|
| Year of Publication: |
2021 |
|---|
| Contained In: |
Canadian journal of ophthalmology. Journal canadien d'ophtalmologie - Vol. 56, No. 2 (2021), p. 145 |
|---|
| Language: |
English |
|---|
| Contributors: |
|---|
| Links: |
|---|
| Notes: |
Date Completed 02.04.2021 Date Revised 02.04.2021 published: Print-Electronic Citation Status MEDLINE Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine |
|---|
| Physical Description: |
Online-Ressource |
|---|
| doi: |
10.1016/j.jcjo.2020.08.010 |
|---|---|
| PMID: |
33007222 |
| PPN (Catalogue-ID): |
NLM316741965 |
|---|
| LEADER | 02771nma a2200697 c 4500 | ||
|---|---|---|---|
| 001 | NLM316741965 | ||
| 003 | DE-601 | ||
| 005 | 20210403213618.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201003s2021 000 0 eng d | ||
| 024 | 7 | |a 10.1016/j.jcjo.2020.08.010 |2 doi | |
| 028 | 5 | 2 | |a pubmed21n1217.xml |
| 035 | |a S0008-4182(20)30735-3 | ||
| 035 | |a (DE-599)NLM33007222 | ||
| 040 | |b ger |c GBVCP | ||
| 041 | 0 | |a eng | |
| 100 | 1 | |a Janetos, Timothy M | |
| 245 | 1 | 0 | |a Lid abscess associated with personal protective eyewear in a COVID-19 medical unit |h Elektronische Ressource |
| 300 | |a Online-Ressource | ||
| 500 | |a Date Completed 02.04.2021 | ||
| 500 | |a Date Revised 02.04.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 500 | |a Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine | ||
| 611 | 2 | 7 | |a Case Reports |2 gnd |
| 611 | 2 | 7 | |a Journal Article |2 gnd |
| 653 | 2 | |a Abscess |6 D000038 |a diagnosis |6 Q000175 |a drug therapy |6 Q000188 |a *etiology |6 Q000209 | |
| 653 | 2 | |a Amoxicillin-Potassium Clavulanate Combination |6 D019980 |a therapeutic use |6 Q000627 | |
| 653 | 2 | |a Anti-Bacterial Agents |6 D000900 |a therapeutic use |6 Q000627 | |
| 653 | 2 | |a COVID-19 |6 D000086382 |a *epidemiology |6 Q000453 | |
| 653 | 2 | |a Disinfectants |6 D004202 |a *adverse effects |6 Q000009 | |
| 653 | 2 | |a Eye Protective Devices |6 D005135 |a *adverse effects |6 Q000009 | |
| 653 | 2 | |a Eyelid Diseases |6 D005141 |a diagnosis |6 Q000175 |a drug therapy |6 Q000188 |a *etiology |6 Q000209 | |
| 653 | 2 | |a Female |6 D005260 | |
| 653 | 2 | |a Humans |6 D006801 | |
| 653 | 2 | |a Intensive Care Units |6 D007362 | |
| 653 | 2 | |a *SARS-CoV-2 |6 D000086402 | |
| 653 | 2 | |a Trimethoprim, Sulfamethoxazole Drug Combination |6 D015662 |a therapeutic use |6 Q000627 | |
| 653 | 2 | |a Young Adult |6 D055815 | |
| 655 | 7 | |a Anti-Bacterial Agents |2 gnd | |
| 655 | 7 | |a Disinfectants |2 gnd | |
| 655 | 7 | |a Amoxicillin-Potassium Clavulanate Combination |2 gnd | |
| 655 | 7 | |a 74469-00-4 |2 gnd | |
| 655 | 7 | |a Trimethoprim, Sulfamethoxazole Drug Combination |2 gnd | |
| 655 | 7 | |a 8064-90-2 |2 gnd | |
| 689 | 0 | 0 | |A f |a Case Reports |
| 689 | 0 | 1 | |A f |a Journal Article |
| 689 | 0 | |5 DE-601 | |
| 689 | 2 | 0 | |a Anti-Bacterial Agents |
| 689 | 2 | 1 | |a Disinfectants |
| 689 | 2 | 2 | |a Amoxicillin-Potassium Clavulanate Combination |
| 689 | 2 | 3 | |A r |a 74469-00-4 |
| 689 | 2 | 4 | |a Trimethoprim, Sulfamethoxazole Drug Combination |
| 689 | 2 | 5 | |A r |a 8064-90-2 |
| 689 | 2 | |5 DE-601 | |
| 700 | 1 | |a Thyparampil, Preeti J | |
| 773 | 0 | 8 | |i in |t Canadian journal of ophthalmology. Journal canadien d'ophtalmologie |g Vol. 56, No. 2 (2021), p. 145 |q 56:2<145 |w (DE-601)NLM000001589 |x 1715-3360 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1016/j.jcjo.2020.08.010 |3 Volltext |
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 56 |j 2021 |e 2 |b 30 |c 04 |h 145 | ||